Jérôme Bailly

Jérôme Bailly

Corporate Officer/Principal at PHAXIAM THERAPEUTICS S.A.

Net worth: 1 223 $ as of 30/03/2024

45 year
Health Technology
Consumer Services

Profile

Jérôme Bailly is currently the Chief Quality Officer & Deputy CEO at PHAXIAM Therapeutics SA, and also holds a managerial position at Gelfruit SARL.
Previously, he worked as the Director-Quality Assurance & Production at SkyePharma Plc, Head-Quality Assurance & Production at Laboratoire Aguettant SAS, and Director-Pharmaceutical Operations at ERYTech Pharma SA. He received his undergraduate and doctorate degrees from Corporation de l'École Polytechnique de Montréal in 2000 and 2003, respectively.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
27/03/2023 380 ( 0.01% ) 1 223 $ 30/03/2024

Jérôme Bailly active positions

CompaniesPositionStart
PHAXIAM THERAPEUTICS S.A. Corporate Officer/Principal 22/06/2023
Gelfruit SARL Corporate Officer/Principal -
All active positions of Jérôme Bailly

Former positions of Jérôme Bailly

CompaniesPositionEnd
Corporate Officer/Principal -
SKYEPHARMA PLC Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Jérôme Bailly's experience

Training of Jérôme Bailly

Corporation de l'École Polytechnique de Montréal Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jérôme Bailly's experience

Connections

24

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
PHAXIAM THERAPEUTICS S.A.

Health Technology

Private companies4

Health Technology

Health Technology

Health Technology

Gelfruit SARL

See company connections
  1. Stock Market
  2. Insiders
  3. Jérôme Bailly